Skip to content

Frontlight ResearchEarly access

Institution

Yonsei Cancer Hospital

Seoul, South KoreaWebsite

Also known as: Yonsei Cancer Center · 연세대학교 암병원 · 연세대학교 암센터 · 연세암병원

3running trials
1closed trial
1researcher
5,757publications (OpenAlex)

Researchers

Woo Jin Hyung

Running trials

Not yet recruiting
A Phase IIb Randomized Clinical Trial of Immune Checkpoint Inhibitor-based Maintenance Therapy in Patients With Advanced Biliary Tract Cancer
NCT07269158· Phase 1/2· Yonsei University· Source
Recruiting
Trastuzumab Deruxtecan vs Endocrine Therapy in Low-HER2 HR+ Advanced Breast Cancer
NCT06837792· Phase 2· Yonsei University· Source
Recruiting
Observation Study to Evaluate the Efficacy and Safety of Ifosfamide/Mesna in Patients With Metastatic Castration-resistant Prostate Cancer
NCT06236789· Yonsei University· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Liver and biliary tract cancer1 recruiting
Metastatic breast cancer1 recruiting
Prostate cancer1 recruiting

Closed trials

Terminated
A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)
NCT03281369· Phase 1/2· Hoffmann-La Roche· Source

Registry name variants (4)

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea
Seoul
1 trial
- NCT06236789Observation Study to Evaluate the Efficacy and Safety of Ifosfamide/Mesna in Patients With Metastatic Castration-resistant Prostate Cancer
  Contact: Sang Joon Shin
Division of Medical Oncology, Yonsei Cancer Center, Yonsei Univ. College of Medicine
Seoul
1 trial
- NCT06837792Trastuzumab Deruxtecan vs Endocrine Therapy in Low-HER2 HR+ Advanced Breast Cancer
  Contact: Joohyuk sohn
Division of Medical Oncology, Yonsei Cancer Center, Yonsei Univ. College of Medicine, Korea
Seoul
1 trial
- NCT07269158A Phase IIb Randomized Clinical Trial of Immune Checkpoint Inhibitor-based Maintenance Therapy in Patients With Advanced Biliary Tract Cancer
Yonsei University College of Medicine (YUCM)-Yonsei Cancer Center
Seoul
1 trial
- NCT03281369A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)

Conditions

Diseases this institution publishes on or runs trials for.

Lung cancer128 works · 0 trials
Gastric and oesophageal cancer50 works · 1 trial
Metastatic breast cancer16 works · 1 trial
Endometrial cancer14 works · 0 trials

Institution data: ROR 0005vby86 (CC0-1.0)Updated 14 Nov 2026

Report an error